Journal
ANALYTICAL CHEMISTRY
Volume 95, Issue 10, Pages 4605-4611Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.2c04244
Keywords
-
Categories
Ask authors/readers for more resources
Array-based sensing methods with a fluorescent sensor array that combines nanoenzymes and bioenzymes have been developed for the detection of amyloids, allowing for the accurate diagnosis of early-stage Alzheimer's disease. Through the use of machine learning algorithms, a simplified sensor array is created, which can amplify the signals and achieve 100% accuracy in discriminating the aggregation species and kinetics at a concentration of 200 nM. Additionally, the sensor array can also differentiate between AD model mice and healthy mice with 100% accuracy, providing a powerful tool for diagnosing AD.
Array-based sensing methods offer significant advantages in the simultaneous detection of multiple amyloid biomarkers and thus have great potential for diagnosing early-stage Alzheimer's disease. Yet, detecting low concentrations of amyloids remains exceptionally challenging. Here, we have developed a fluorescent sensor array based on the dual coupling of a nanoenzyme (AuNPs) and bioenzyme (horseradish peroxidase) to detect amyloids. Various ss-DNAs were bound to the nanoenzyme for regulating enzymatic activity and recognizing amyloids. A simplified sensor array was generated from a screening model via machine learning algorithms and achieved signal amplification through a two-step enzymatic reaction. As a result, our sensing system could discriminate the aggregation species and aggregation kinetics at 200 nM with 100% accuracy. Moreover, AD model mice and healthy mice were distinguished with 100% accuracy through the sensor array, providing a powerful sensing platform for diagnosing AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available